J Hirsh, JE Dalen, DR Anderson, L Poller, H … - Chest, 2001 - chestjournal.chestpubs.org The optimal therapeutic range for oral anticoagulant therapy was reviewed by the
Committee on Antithrombotic Therapy of the American College of Chest Physicians
and the National Heart, Lung, and Blood Institute in 1986, 1989, 1992, ... Cited by 1399 - Related articles - BL Direct - All 23 versions
TM Hyers, G Agnelli, RD Hull, TA Morris, M … - Chest, 2001 - chestjournal.chestpubs.org Antithrombotic regimens modify one or more of these abnormalities. These
regimens include drugs that inhibit blood coagulation, such as the various
heparins and heparinoids; warfarin; direct thrombin inhibitors; drugs that ... Cited by 1090 - Related articles - BL Direct - All 28 versions
- ►chestpubs.org J Ansell, J Hirsh, E Hylek, A Jacobson, M … - Chest, 2008 - chestjournal.chestpubs.org This article concerning the pharmacokinetics and pharmacodynamics of vitamin K
antagonists (VKAs) is part of the American College of Chest Physicians
Evidence-Based Clinical Practice Guidelines (8th Edition). It describes the ... Cited by 903 - Related articles - BL Direct - All 21 versions
JS Levine, D Branch, J Rauch - The New England Journal of Medicine (CME), 2002 - cme.nejm.org From the Department of Medicine, Section of Nephrology, University of Chicago,
Chicago (JSL); the Department of Obstetrics and Gynecol- ogy, University of
Utah, Salt Lake City (DWB); and the Department of Medicine, Division of ... Cited by 828 - Related articles - View as HTML - BL Direct - All 8 versions
J Ansell, J Hirsh, J Dalen, H Bussey, D … - Chest, 2001 - chestjournal.chestpubs.org Several important developments in the last 2 decades have improved clinical
outcomes with oral anticoagulation therapy and have led to an appropriate
increase in the use of this therapy by improving its safety. These ... Cited by 468 - Related articles - BL Direct - All 7 versions
- ►ahajournals.org J Hirsh, V Fuster, J Ansell, JL Halperin - Journal of the American College of Cardiology, 2003 - Elsevier Warfarin, a coumarin derivative, produces an anticoagulant effect by interfering
with the cyclic interconversion of vitamin K and its 2,3 epoxide (vitamin K
epoxide). Vitamin K is a cofactor for the carboxylation of glutamate ... Cited by 358 - Related articles - BL Direct - All 20 versions
- ►hem-aids.ru [PDF] RL Bick - Hematology/oncology clinics of North America, 2003 - Elsevier Antiphospholipid thrombosis syndromes, which include not only the lupus
anticoagulant (LA) and anticardiolipin antibodies (ACLAs) but also more recently
recognized “subgroups” of antiphospholipid antibodies (antibodies ... Cited by 228 - Related articles - BL Direct - All 14 versions
TM HYERS - American journal of respiratory and critical care …, 1999 - 171.66.122.149 Venous thromboembolism (VTE) is a complex vascular disease with a multifactorial
pathogenesis that results in two major clinical manifestations. The first and
more common manifestation is deep venous thrombosis (DVT), which usually ... Cited by 174 - Related articles - BL Direct - All 6 versions
JD Olson, CF Arkin, JT Brandt, TC … - Arch Pathol Lab Med, 1998 - cap.org 782 Arch Pathol Lab Med—Vol 122, September 1998 ... Monitoring of Heparin
Therapy—Olson et al ... College of American Pathologists Conference XXXI on ... John D. Olson, MD, PhD; Charles F. Arkin, MD; John T. Brandt, MD; Mark ... Cited by 166 - Related articles - View as HTML - BL Direct - All 8 versions
- ►hematologylibrary.org M Galli, T Barbui - Blood, 1999 - bloodjournal.hematologylibrary.org In 1959 Loeliger 19 described a case whose lupus anticoagulant activity was more
pronounced in a mixture of the patient's plasma with normal plasma than in the
patient's own plasma. The patient's plasma prothrombin was low. Elegant ... Cited by 130 - Related articles - BL Direct - All 4 versions
